Skip to main content
. 2020 Sep 1;99(11):5598–5606. doi: 10.1016/j.psj.2020.08.044

Table 2.

Effect of in ovo feeding of a commercial product containing canthaxanthin at 17.5 d of embryo development on residual analysis (%) among unhatched eggs relative to the total number of incubated eggs.

Residual analysis (%) Commercial product containing canthaxanthin (mg/0.5 mL/egg)
0.00 0.35 0.45 0.55 0.65 P-value
Infertile eggs 9.50 8.50 7.90 8.10 9.25 0.5946
MI 2.60 2.24 2.23 3.16 2.99 0.9874
MII 2.20 1.00 2.51 1.35 2.90 0.5587
MIII 1.80 1.77 3.34 1.64 1.85 0.0910
MIV 1.27b 3.90b 10.31a 19.14a 19.62a >0.0001
Pipped dead 1.10c 6.33b 9.20a 15.90a 12.91a >0.0001
Pipped alive 0.80b 6.33a 6.51a 9.90a 11.1a >0.0001
Abnormal alive 0.15 0.00 0.52 0.00 0.00 1.0000
Abnormal dead 0.00 0.00 0.00 0.00 0.00 0.9211
Unpipped alive 0.50b 4.81a 3.11a 5.12a 6.55a 0.0153
Contaminated eggs 1.10 0.50 0.00 0.87 0.00 0.124

a–cMeans within a row with different superscript letters are different by Fisher Exact test (P < 0.05).

Abbreviations: MI, mortality from 0 to 4 d of embryo development; MII, mortality from 5 to 10 d of embryo development; MIII, mortality from 11 to 17 d of embryo development; MIV, mortality from 18 to 21 d of embryo development.